Advertorial

Dear [Full Name]

This is a reminder that you have registered to view a Live Broadcast on a new treatment option for adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, including DLBCL arising from follicular lymphoma, after at least 2 lines of systemic therapy.

Thank you for your participation!

  • Date: 7/15/20

  • Time: 12:30pm

  • To view the broadcast, please click here.

VIEW LIVE BROADCAST

 

For full Prescribing Information, Click Here

Faculty information

Pharmaceutical Technology Pii

Michael W. Schuster, MD

Professor of Medicine
Stony Brook University Hospital

Pharmaceutical Technology Pii

Yair Levy, MD

Director of Heme Malignancies Research
Baylor University Medical Center

 
VIEW LIVE BROADCAST
Pharmaceutical Technology Pii

 

This Live Broadcast is sponsored by Karyopharm Therapeutics Inc.
© 2020 Karyopharm Therapeutics Inc. All rights reserved.
US-XPOV-05/20-00030

 

Onclive – an MJH Life Sciences brand
Copyright 2020 © Intellisphere, LLC
2 Clarke Drive, Suite 100
Cranbury, NJ 08512

Preferences  |  Unsubscribe